Latest / Viewpoint Alabama / Southern Research and the Catalyst Program
Transcript
- 0:01Speaker 1: Living better through scientific advances that are achieved right here
- 0:04Speaker 1: in our state. Hello, and welcome to Viewpoint Alabama on
- 0:07Speaker 1: the Alabama Radio Network. My name is John Mounts, and
- 0:10Speaker 1: I'm always excited to tell good news stories about businesses
- 0:13Speaker 1: and research organizations in our state making a difference. And
- 0:17Speaker 1: one of the ones you might not be familiar with
- 0:19Speaker 1: but you should is Southern Research, located right here in Birmingham, Alabama.
- 0:23Speaker 1: And I'm joined right now by the chief medical officer
- 0:26Speaker 1: at Southern Research, doctor Khalila Brown. Doctor Brown, tell me
- 0:30Speaker 1: first of all, what is Southern Research all about?
- 0:33Speaker 2: So?
- 0:33Speaker 3: Southern Research is an eighty three year old translational research institute.
- 0:38Speaker 3: We've been doing great work in Birmingham in the tech space,
- 0:43Speaker 3: mostly the biotech space life sciences space for a very
- 0:47Speaker 3: long time.
- 0:49Speaker 2: I think a lot of people don't.
- 0:50Speaker 3: Realize that we're here, and probably a well kept secret,
- 0:54Speaker 3: but fifty percent of the chemo therapy is currently used
- 0:57Speaker 3: in the United States came through Southern Research.
- 1:00Speaker 2: Point time.
- 1:01Speaker 3: So really excited that we do a lot of work
- 1:03Speaker 3: that touches not only Alabamians, but people in nationwide and worldwide.
- 1:07Speaker 1: Do you work with UAB at all? Since you're so close.
- 1:09Speaker 3: Correct, that's a great thing. So Southern research actually pre
- 1:13Speaker 3: dates UAB, but you AB. I'm a two time graduate
- 1:17Speaker 3: of u A B and super proud that it's here
- 1:19Speaker 3: and that we get to work alongside them. We are
- 1:22Speaker 3: now an affiliate of ua B and so we kind
- 1:25Speaker 3: of sit in the middle zone of the research. So
- 1:28Speaker 3: UAB does a lot of the basic sciences and then
- 1:31Speaker 3: we do that translational part, so everything from when it
- 1:34Speaker 3: becomes an idea before it touches a patient to validate
- 1:38Speaker 3: does it work, how does it work?
- 1:40Speaker 2: Is it safe?
- 1:41Speaker 3: And then it goes back to institutes like UAB and
- 1:44Speaker 3: others throughout the world when it hits patient.
- 1:46Speaker 1: And that way you can let UAB handle all the
- 1:48Speaker 1: messy work with all the paperwork and the patients and
- 1:50Speaker 1: all that kind of stuff.
- 1:51Speaker 2: When it comes to the trials, yes they have the
- 1:53Speaker 2: clinical trials.
- 1:54Speaker 3: Once they hit the patient, there's still a lot of
- 1:56Speaker 3: paperwork because it's just it's a highly regular industry.
- 2:00Speaker 1: The human use forms are very very long and complicated.
- 2:04Speaker 2: Yes, we want to know that things are very safe.
- 2:06Speaker 1: Extuctly, and they should I was going to say, and
- 2:07Speaker 1: they should be because I don't want you know stuff
- 2:09Speaker 1: being tested on me unless you know, we know it's
- 2:11Speaker 1: going to actually be safe. So well, doctor Brown, the
- 2:14Speaker 1: reason we're in here specifically to talk is something that
- 2:17Speaker 1: Southern Research is involved in. It's a new project. It's
- 2:20Speaker 1: called the Catalyst Project, and Catalyst is going to I
- 2:24Speaker 1: think be very beneficial to a lot of people. Tell
- 2:26Speaker 1: me what inspired the Catalyst program and what it helps
- 2:30Speaker 1: to achieve.
- 2:31Speaker 3: So Catalyst is a new foray for Southern Research. Remember
- 2:34Speaker 3: I just told you we've been all about pre clinical
- 2:38Speaker 3: things that really didn't touch patients. But because we are
- 2:43Speaker 3: a nonprofit research institute, we sit at a unique juncture
- 2:46Speaker 3: that allows us to do things that other healthcare institutes
- 2:51Speaker 3: may not be able to do. And so we have
- 2:52Speaker 3: funding from the state of Alabama that really is meant
- 2:55Speaker 3: to increase precision medicine to patients throughout the state, regardless
- 2:59Speaker 3: of their insurance, in order to really impact chronic disease management.
- 3:04Speaker 3: So we know that we've got a lot of uninsured
- 3:07Speaker 3: patients in Alabama. We've got rural patients that have, you know,
- 3:10Speaker 3: issues with access to healthcare. So how do we take
- 3:13Speaker 3: care how do we help those healthcare providers that are
- 3:15Speaker 3: in rural areas, underserved areas, even if you're right here
- 3:18Speaker 3: in Birmingham have information that helps them take better care
- 3:22Speaker 3: of their patient.
- 3:23Speaker 1: When they first rolled out the human genome map back
- 3:26Speaker 1: in what year was that those about nineties? You know,
- 3:29Speaker 1: over twenty years yeh, it's been at least twenty years.
- 3:31Speaker 1: I thought, you know, this is going to really do
- 3:34Speaker 1: incredible things for science. And then you combine that with
- 3:37Speaker 1: the recent all the recent explosion of AI, because AI
- 3:40Speaker 1: can do all those little tiny tasks that would take
- 3:42Speaker 1: you know, a whole building full of people, you know,
- 3:44Speaker 1: years to do, AI can do it in a matter
- 3:46Speaker 1: of minutes. So you combine the human geno mapping and AI,
- 3:50Speaker 1: you can do some amazing things if we have some
- 3:52Speaker 1: data from individual people. And I think that's kind of
- 3:55Speaker 1: what Catalyst is getting at, right, That's.
- 3:57Speaker 3: That's definitely it's what it's getting at on two sides
- 4:00Speaker 3: of the same coin. So on the front end, we're
- 4:03Speaker 3: offering this testing that has it's a clinical test. It's
- 4:06Speaker 3: not a research great test. It's a clinical test that
- 4:08Speaker 3: goes back to your health care provider that gives you
- 4:10Speaker 3: three great reports that tells your health care provider one,
- 4:13Speaker 3: what are your risk around type two diabetes coordinator or disease,
- 4:16Speaker 3: and breast cancer for your biological female. It also tells
- 4:20Speaker 3: you about how you handle specific drug medications, common things
- 4:23Speaker 3: that we take every day, where they're there antidepressants, ADHD medications,
- 4:28Speaker 3: heart disease medications, simple things like aspirin, motor and talentol,
- 4:32Speaker 3: all those things.
- 4:33Speaker 2: How does your body handle those? What does your.
- 4:35Speaker 3: Genome say about that? And so it may or may
- 4:38Speaker 3: not be the right medication for you. So we're hopefully
- 4:40Speaker 3: helping people understand what medications work best for them, rather
- 4:44Speaker 3: than them having to try them and see they have
- 4:45Speaker 3: side effects or they don't work right. And then there's
- 4:49Speaker 3: a rare disease report, and I need people to understand
- 4:51Speaker 3: that rare disease isn't always as rare as you think.
- 4:55Speaker 3: So it's eighty four genes that translates to about forty
- 4:57Speaker 3: four disease states that we we deal with every day.
- 5:01Speaker 3: So familiar hypercholesterolemia long QT syndrome, which is a cardiac
- 5:06Speaker 3: a rhythmia defect that can cause you to you know,
- 5:09Speaker 3: have an rhythmia and delight cap collapse and die very quickly.
- 5:13Speaker 3: Marphin syndrome, brackaging, for breast cancers. On there, they're screening
- 5:18Speaker 3: for prostate cancers. So just making sure people understand not
- 5:21Speaker 3: just what their clinical risk is, but now what is
- 5:24Speaker 3: my genetic risk? And so how does that help my
- 5:26Speaker 3: healthcare provider have an insight into a window that they
- 5:30Speaker 3: typically don't have access to because it's not typically something
- 5:33Speaker 3: that's paid for by insurance unless you're looking for a
- 5:37Speaker 3: specific disease state.
- 5:38Speaker 1: And that's so important. You know, your doctor always wants
- 5:41Speaker 1: to know your family history, and sometimes we don't have
- 5:43Speaker 1: complete family history. Maybe our you know, we were born
- 5:46Speaker 1: late in life, and you know, we don't know our
- 5:48Speaker 1: grandparents or our great grandparents. We have no idea what
- 5:50Speaker 1: they die from, and so that's a mystery to us.
- 5:53Speaker 1: So something like this could be very helpful not only
- 5:56Speaker 1: to us, but to our children, to our nieces, our nephews,
- 5:59Speaker 1: other family members, because they could very well benefit from
- 6:02Speaker 1: this information as well, right, correct.
- 6:04Speaker 3: And that's the great thing about one put it in
- 6:06Speaker 3: the hands of your health care provider who can help
- 6:08Speaker 3: you understand it. But on the back end of this program,
- 6:11Speaker 3: every participant in every healthcare provider has free access to
- 6:14Speaker 3: genetic counselors. So now we have the information, but how
- 6:17Speaker 3: does that translate not just to my health, but to
- 6:20Speaker 3: my family's health. We want to make sure that we
- 6:22Speaker 3: understand how it's inherited, and so who would impact Should
- 6:25Speaker 3: I call my sister, Should I call my brother or
- 6:27Speaker 3: my cousin or my aunt? Who are the right people
- 6:29Speaker 3: that I should be talking to about this, because so
- 6:32Speaker 3: often we just don't have a clear picture of our
- 6:35Speaker 3: family history. Even when we have history, it's not always correct.
- 6:38Speaker 3: You know, We've had ten men in our family collapse
- 6:41Speaker 3: and everybody thought it was because they were obese and
- 6:44Speaker 3: they smoked, but really we had some type of familial
- 6:47Speaker 3: cardiomyopathy that was missed, and so we don't know those
- 6:51Speaker 3: types of things just because you know, again we didn't
- 6:54Speaker 3: pass down the right name of it, or maybe we
- 6:56Speaker 3: didn't know the right name of it. We never got
- 6:57Speaker 3: an autopsy. And so we're trying to make sure that
- 7:00Speaker 3: people have a window into those things. And then on
- 7:02Speaker 3: the back end of that, we can use that data.
- 7:05Speaker 3: So now, as you say, with AIAI only spits out
- 7:07Speaker 3: things that's already.
- 7:08Speaker 1: In the system, garbage in, garbage out, correct.
- 7:11Speaker 2: So we need good data in.
- 7:12Speaker 3: We need data that's representative of Alabama, and so when
- 7:16Speaker 3: you look at the data set, we're not there, We're
- 7:18Speaker 3: not represented. Nobody's come into Alabama really to do research
- 7:22Speaker 3: and make us part of their data set. They're going
- 7:24Speaker 3: to California and Texas and New York, and so we
- 7:26Speaker 3: get things on the back end. Our medications aren't always
- 7:29Speaker 3: built for us here in Alabama. And we're a unique
- 7:33Speaker 3: data set, we really are. We're a non transient state,
- 7:36Speaker 3: so about seventy percent of people born in the state,
- 7:39Speaker 3: say in the state. So we've got generations of data.
- 7:42Speaker 3: We've got significant chronic disease. So we're a great place
- 7:46Speaker 3: to make sure that these medications work properly, and so
- 7:49Speaker 3: we want the data to prove it on the front
- 7:51Speaker 3: end before it ever hits our bodies.
- 7:53Speaker 1: That's a great point, the fact that we are so
- 7:55Speaker 1: insular and we don't have a lot of people who
- 7:57Speaker 1: move to Alabama, and we don't have a lot of people,
- 8:00Speaker 1: especially not a lot of people leave because Alabama's a
- 8:02Speaker 1: great place. Why would you want to leave here? But
- 8:04Speaker 1: that makes sense why it is that we do need
- 8:05Speaker 1: research very specific to our region. And I would imagine
- 8:09Speaker 1: this information not only as helpful to individuals and their families.
- 8:12Speaker 1: But also as you amass all of this data, it
- 8:14Speaker 1: kind of goes into larger database, so we're better able
- 8:17Speaker 1: to understand whole populations of people. Are you able? Can
- 8:20Speaker 1: you talk some about that how it's able to help
- 8:22Speaker 1: individual populations of people.
- 8:24Speaker 3: So people who consent, are able to consent to have
- 8:27Speaker 3: us have access.
- 8:28Speaker 2: To their de identified information.
- 8:30Speaker 3: So we take away your name, your data, birth, all
- 8:33Speaker 3: the things that would be somebody would be able to
- 8:35Speaker 3: identify you as a person from now. Granted your genome
- 8:39Speaker 3: identifies you who you are, but being able to take
- 8:43Speaker 3: that information in a more global perspective. So in Alabama
- 8:47Speaker 3: we have a high rate of breast cancer and heart disease.
- 8:50Speaker 3: Can we look at that from a population level, right,
- 8:54Speaker 3: and then decide are there certain treatments that work better
- 8:57Speaker 3: for us here based.
- 8:58Speaker 2: On you know, is there a gene variant?
- 9:01Speaker 3: Is there some type of target that we can use
- 9:03Speaker 3: a lot of times what you see as people and
- 9:06Speaker 3: different pharma companies repurposing medication. So a thing was originally
- 9:11Speaker 3: designed for one thing and it didn't work, but I
- 9:13Speaker 3: had a side effect that as a side effect that
- 9:16Speaker 3: worked for something else, Right, So now we have data
- 9:18Speaker 3: and we can say, oh, maybe we can try this.
- 9:21Speaker 3: So this is how we pull in things that have
- 9:23Speaker 3: already the billions of dollars have already been spent and
- 9:26Speaker 3: it's sitting in a vault somewhere. But now we realize
- 9:29Speaker 3: it can be used for something else. Like we have
- 9:31Speaker 3: medication meant for diabetes, but now we know it works
- 9:33Speaker 3: for weight loss. So how do we repurpose that for
- 9:36Speaker 3: a completely different subset of the population to benefit them
- 9:39Speaker 3: as well. So there's lots of things that can be
- 9:42Speaker 3: done with those data sets, but we want to make
- 9:44Speaker 3: sure first that Alabama is represented.
- 9:46Speaker 1: Now you mentioned this a little touch on a little bit,
- 9:48Speaker 1: but I wanted to go into it a little deeper.
- 9:50Speaker 1: The safety of the data, this being you know, there's
- 9:52Speaker 1: a lot of concern about anything from my financial information too.
- 9:56Speaker 1: I could even see stuff like this where if it
- 9:59Speaker 1: were to it out to say my insurance provider that
- 10:03Speaker 1: I have a proclivity for certain illness, they might not
- 10:06Speaker 1: cover me. They might say, well, that's actually pre existing.
- 10:08Speaker 1: How do we protect the safety of the data from
- 10:12Speaker 1: getting out there and actually harming those people who participate.
- 10:15Speaker 3: So first and foremost, there is a law called the
- 10:17Speaker 3: GENA Act. The Genetic Information Non Discrimination Act. That means
- 10:21Speaker 3: that your healthcare provider or your health care insurance entity
- 10:25Speaker 3: does not have any right to your genetic information. You
- 10:28Speaker 3: have to share it with them and what your risk
- 10:31Speaker 3: are from that, and so we don't supply any of
- 10:33Speaker 3: that to any type of health care institution or anyone
- 10:37Speaker 3: doing anything like that. We've also hired an amazing chief
- 10:41Speaker 3: data officer who's done this for many many years at
- 10:45Speaker 3: m D. Anderson and at Baylor College of Medicine. This
- 10:49Speaker 3: is what he's built his career on and so we
- 10:51Speaker 3: were really lucky to get him here to Alabama to
- 10:54Speaker 3: help us build this data set. So we've built in
- 10:56Speaker 3: a lot of security from a lot of different ways.
- 11:00Speaker 3: So the information that a patient fills out on what
- 11:03Speaker 3: we call their patient portal, which would be their identifying information,
- 11:06Speaker 3: their name, their address on their phone number that lives
- 11:09Speaker 3: in one system, right, they.
- 11:11Speaker 2: Take their surveys there.
- 11:12Speaker 3: So we do social determinants of health because we understand
- 11:15Speaker 3: that Robert what Johnson says eighty percent of your health
- 11:18Speaker 3: outcomes actually come from your social determinants of health, not
- 11:21Speaker 3: from your clinical care. So we want to make sure
- 11:23Speaker 3: that healthcare providers know that about their patients. So all
- 11:26Speaker 3: of those things live in this data set that is
- 11:29Speaker 3: your patient portal. Your genetic information again is deidentified from
- 11:34Speaker 3: that and housing a completely different set. And so we've
- 11:38Speaker 3: made this structural segregation for a lot of different ways.
- 11:42Speaker 3: We don't want somebody to be able to have access
- 11:44Speaker 3: to one system and know everything about you.
- 11:46Speaker 2: So even if someone somehow.
- 11:48Speaker 3: Got access to this super lockdown system, they would then
- 11:51Speaker 3: have to be able to have access to both systems
- 11:54Speaker 3: and then figure out what the crosswalk is to put
- 11:56Speaker 3: you together with this other data set to figure out
- 11:59Speaker 3: that it's you. And that's something that we've learned from
- 12:01Speaker 3: missteps that of other programs, not here in Alabama, but
- 12:05Speaker 3: they're like.
- 12:06Speaker 1: You've heard about twenty three and meters how they're about
- 12:08Speaker 1: ready to go belly up, and so there's a concern
- 12:10Speaker 1: that well wears all that data going to go that
- 12:12Speaker 1: they've amassed. So that's why I guess, you know, you
- 12:15Speaker 1: guys have been more careful with it, which makes a
- 12:17Speaker 1: lot of sense because you're you're smart, there's Southern research,
- 12:19Speaker 1: you know what you're doing.
- 12:20Speaker 3: Yeah, we're doing our best to make sure that people
- 12:23Speaker 3: feel confident that what we're doing keeps them safe. And
- 12:27Speaker 3: that's a great thing about us being in Alabama based nonprofit.
- 12:30Speaker 3: It's not like you're having a drive to New York
- 12:32Speaker 3: or call somebody in California. We're right here. So if
- 12:34Speaker 3: you have questions, we're homegrown. We're home home based, and
- 12:37Speaker 3: so we're built here for Alabama, serving Alabama, and so
- 12:41Speaker 3: you can show up on our front doorstep if you'd
- 12:43Speaker 3: like and ask about your data. There's a way to actually,
- 12:45Speaker 3: you know, pull your data out if you would like to.
- 12:48Speaker 3: You know, you've consented, you've participated, and now you said, hey,
- 12:50Speaker 3: I really don't think I'm comfortable with this anymore, or
- 12:53Speaker 3: I don't want to be a part of this anymore.
- 12:55Speaker 3: There's always a way to say, Okay, I no longer consent.
- 12:58Speaker 3: And that's part of what you know. People don't we
- 13:01Speaker 3: hear a lot about what's gone on in research in
- 13:03Speaker 3: our states, specifically in Alabama, because we do have a
- 13:06Speaker 3: lot of mistrust.
- 13:07Speaker 2: We've made a lot of missteps.
- 13:08Speaker 3: In our history, but we are we are also much
- 13:13Speaker 3: like civil rights.
- 13:13Speaker 2: I don't think people will realize that the.
- 13:15Speaker 3: Pioneering of consenting and ethical medical treatment was born right
- 13:19Speaker 3: here in Alabama.
- 13:20Speaker 1: Well after that civilist thing. I'm sure that's what you're
- 13:23Speaker 1: referring to. Yeah, Ever since that, I'm sure there's a
- 13:25Speaker 1: lot of people who are very concerned about that in Alabama,
- 13:27Speaker 1: and so we led.
- 13:29Speaker 2: The charge for that.
- 13:30Speaker 3: We have the Center of Bioethics that now lives at
- 13:33Speaker 3: Tuskegee who make sure worldwide that we're doing ethical research.
- 13:37Speaker 3: So we have learning from our past and we're getting better.
- 13:41Speaker 3: We're being better, we're being ethical. And that's the great
- 13:44Speaker 3: thing about having Tuskegee and the UABS that's you know,
- 13:47Speaker 3: fourth and nih is funding and doing all the great
- 13:49Speaker 3: work that they do. That we're all committed to doing
- 13:52Speaker 3: things and doing them the right way and making sure
- 13:54Speaker 3: that Alabama stays at the top of that research. So
- 13:57Speaker 3: we're informing not just Alabama, but nationwide and worldwide. We
- 14:01Speaker 3: really are pioneering treatments that help people worldwide.
- 14:04Speaker 1: So, doctor Brian, you've given us a lot of good
- 14:06Speaker 1: reasons why you should participate in this project. So how
- 14:10Speaker 1: do people participate?
- 14:11Speaker 3: So you can go to Catalysts by Southern Research dot
- 14:14Speaker 3: org or googling to get more information. We've got a
- 14:18Speaker 3: website there. What we're doing right now is really trying
- 14:22Speaker 3: to get the information out to healthcare providers so that
- 14:25Speaker 3: they know what their patients are eligible for.
- 14:28Speaker 2: Again completely free.
- 14:29Speaker 3: We don't take any insurance information from beginning to end,
- 14:33Speaker 3: from your testing all the way through to your genetic
- 14:35Speaker 3: counseling appointment. All that information goes back to the patient
- 14:39Speaker 3: and their healthcare provider, and there's no charge for that.
- 14:42Speaker 3: So we're really lucky in the state that our state
- 14:45Speaker 3: understood the impact from this, not just from a medical standpoint,
- 14:49Speaker 3: but there's also an economic impact. We saw that during
- 14:52Speaker 3: COVID when small businesses had to shut down because of
- 14:55Speaker 3: the health of their staff, and so how do we
- 14:58Speaker 3: redirect that to chronic disease? As our population gets older
- 15:03Speaker 3: and older Americans are working, how can we help them
- 15:07Speaker 3: be healthier so that they can go out and fuel
- 15:10Speaker 3: our economy. They can keep their jobs, they can keep
- 15:12Speaker 3: putting dinner on their table because they're healthier. Health really
- 15:17Speaker 3: is wealth, So how do we help Alabamians really have
- 15:20Speaker 3: a window into their health and help their health care providers?
- 15:23Speaker 1: When you actually talk about the participation process, because we
- 15:27Speaker 1: have listeners not only in Birmingham but also in Mobile,
- 15:30Speaker 1: so it's about a three and a half hour drive
- 15:32Speaker 1: from Mobile, So do you need to go to Birmingham
- 15:35Speaker 1: or can you do these? Can you actually participate from
- 15:37Speaker 1: you know, three hours away?
- 15:38Speaker 3: Yeah, right there with your health care provider in your
- 15:42Speaker 3: clinic where you've already established trust. That's the whole thing
- 15:45Speaker 3: is that it's put in the hands of your health
- 15:48Speaker 3: care provider who can make it actionable in your care.
- 15:51Speaker 3: We know from lots of different studies that people are
- 15:54Speaker 3: more likely to do something if their primary care provider
- 15:57Speaker 3: recommends it, and so we want to make sure that
- 16:00Speaker 3: the person that they trust with their day to day
- 16:02Speaker 3: care has this information, has reviewed it, has talked to
- 16:05Speaker 3: the specialist, and can now say hey, I think this
- 16:07Speaker 3: is what's right for you, or this is a variant
- 16:09Speaker 3: that we've found, this is a problem with this medication,
- 16:12Speaker 3: and they help you make that actionable in your care.
- 16:15Speaker 3: So it puts it in your health care provider's hands
- 16:17Speaker 3: to help you make an informed decision about what's best
- 16:20Speaker 3: for your care.
- 16:20Speaker 1: So they take samples like blood and the usual samples
- 16:24Speaker 1: they would take.
- 16:24Speaker 3: Correct So we're taking two small purple top tubes, just
- 16:29Speaker 3: like you would if you were getting a CBC or
- 16:30Speaker 3: a LIMPID panel during a regular clinic visit. So when
- 16:33Speaker 3: you're going for your regular clinic visit, you tell us
- 16:36Speaker 3: that you're going, we'll send a kit and we just
- 16:39Speaker 3: make sure that the providers have what they need and
- 16:42Speaker 3: then we do that sequencing and get it back to
- 16:44Speaker 3: get it back to healthcare providers through their provider portal.
- 16:46Speaker 1: So in other words, not even an extra stick, just
- 16:48Speaker 1: you know, whyle, they've already got the needle in. You
- 16:50Speaker 1: just draw an extra tube. Correct, That's always very important.
- 16:53Speaker 1: I have minimum sticks is always the best thing. Well,
- 16:56Speaker 1: let's talk about where what's on the horizon. What's next
- 16:59Speaker 1: for cat List Once all this data is a mass
- 17:02Speaker 1: what we already know what's going to benefit me and
- 17:04Speaker 1: my family, But what about the Alabama and the world
- 17:08Speaker 1: at large? What does Catalyst see the future.
- 17:11Speaker 3: As So Number one, as you talked about with AI,
- 17:15Speaker 3: we want to make sure that Alabama is part of
- 17:16Speaker 3: that data set. AI only spits out what's in there
- 17:19Speaker 3: right now, we aren't represented. So we want to make
- 17:21Speaker 3: sure that Alabama is represented there because lots of companies
- 17:25Speaker 3: are using that to design drug targets, to design the
- 17:29Speaker 3: drugs and the treatments for the future. And so we
- 17:32Speaker 3: want to make sure that we're involved in that, that
- 17:34Speaker 3: we're not secondary or on the back end of that.
- 17:37Speaker 3: So often that happens when you're outside of the University
- 17:41Speaker 3: of Alabama at Birmingham or USA and Mobile. If you
- 17:45Speaker 3: live in you know, rural and Dealusia or Florence, are
- 17:48Speaker 3: you getting access to those clinical trials? Usually not, And
- 17:52Speaker 3: so we want to a make sure you're part of
- 17:54Speaker 3: a data set. So we're bringing it to you, but
- 17:57Speaker 3: we're also going to let patients know when they're eligible
- 17:59Speaker 3: for clinical trials, because clinical trials is treatment is.
- 18:02Speaker 2: A real thing.
- 18:03Speaker 3: It is a life saving thing for many many people.
- 18:06Speaker 3: So based on the data that you provide, what clinical
- 18:09Speaker 3: trials are you eligible for?
- 18:11Speaker 2: And again, we want.
- 18:12Speaker 3: You to go back to your primary care provider and
- 18:14Speaker 3: say is this right for me? We don't want to
- 18:16Speaker 3: tell you what we think is right for you or
- 18:18Speaker 3: even what your data says is right for you, because
- 18:20Speaker 3: there's a human component to that. You should be able
- 18:23Speaker 3: to make your health care decisions with your health care provider.
- 18:26Speaker 3: So we give you the information and then say, hey,
- 18:28Speaker 3: sit down with your healthcare provider and talk about whether
- 18:31Speaker 3: or not participation in this is what's right for.
- 18:33Speaker 1: You also as somebody who has participated in some of
- 18:35Speaker 1: those things. Usually there's a little bit of compensation, not always,
- 18:38Speaker 1: but usually so to defray the cost of travel or
- 18:40Speaker 1: whatever else. So you know, it's not just you know,
- 18:43Speaker 1: your time, you're giving up for nothing, you're helping others,
- 18:46Speaker 1: you're helping yourself, and you might actually get a few
- 18:48Speaker 1: bucks on the side.
- 18:49Speaker 2: Correct.
- 18:49Speaker 3: And our hope is as we build this information and
- 18:52Speaker 3: we show that Alabamians participate in research that we want
- 18:56Speaker 3: to know more about our health care, that we want
- 18:58Speaker 3: to be at the forefront. That farmer companies now come
- 19:01Speaker 3: in and they do research with Alabama as opposed to
- 19:04Speaker 3: what's happened in the past doing research on Alabama.
- 19:07Speaker 2: We want to say, hey, come here, be our partners.
- 19:09Speaker 3: Invest in Florence, invest in Coleman, invest in Aniston, invest
- 19:13Speaker 3: in Andalusia, wherever you may be, Dothan, there's great research
- 19:17Speaker 3: being done in small, community based areas.
- 19:20Speaker 2: How do we build that up.
- 19:21Speaker 3: We've got the Health Sciences Academy come into Demopolis, Alabama.
- 19:25Speaker 2: How do we put that there.
- 19:26Speaker 3: We'll have students who are working on this from high
- 19:28Speaker 3: school up. There'll be a nursing school there. So how
- 19:31Speaker 3: do we build a long clinical trials there to provide
- 19:33Speaker 3: access now for patients in Demopolis in Tuscaloosa.
- 19:37Speaker 2: That's the infrastructure we want to build.
- 19:39Speaker 1: So one more time people, We've given them all the
- 19:41Speaker 1: reasons to participate. Where do they need to go and
- 19:44Speaker 1: what do they need to have ready to supply when
- 19:47Speaker 1: they fill out the online forms.
- 19:49Speaker 3: So, if you want to get more information about catalyus
- 19:51Speaker 3: again catallus by Southernresearch dot org.
- 19:54Speaker 2: If you want to learn more, all the information is there.
- 19:57Speaker 2: There's learn more button.
- 19:58Speaker 3: If you're a healthcare provider, you can sign up to
- 20:00Speaker 3: offer the clinical tests to your patient. We want to
- 20:03Speaker 3: make sure that anybody who wants access has access.
- 20:06Speaker 2: And that's how you can get more information.
- 20:08Speaker 1: And once the research is kind of amassed and completed,
- 20:10Speaker 1: I assume that Southern Research, you guys are probably going
- 20:13Speaker 1: to put some stuff on your website. People want to
- 20:14Speaker 1: find out how we're doing because I'd like to see
- 20:17Speaker 1: the report. You know, do we have more of this
- 20:19Speaker 1: and less of that? I think it'd be great for
- 20:21Speaker 1: you know, just just general knowledge.
- 20:23Speaker 4: Yes.
- 20:24Speaker 3: So I spent fourteen years in public health at Jefferson
- 20:26Speaker 3: County Department of Public Health and I know how important
- 20:29Speaker 3: it is to inform what we do in public health
- 20:32Speaker 3: in our state, and so our goal really is to
- 20:34Speaker 3: be able to work with you know, adph.
- 20:37Speaker 2: These local public health.
- 20:38Speaker 3: Departments are federally qualified health centers to say, hey, these
- 20:41Speaker 3: are the things fluence looks different from SELMA, right, these
- 20:45Speaker 3: are the things that maybe we should be focusing more
- 20:47Speaker 3: on influence. We want to make sure that not just
- 20:50Speaker 3: people have benefit from their data.
- 20:52Speaker 2: How do their.
- 20:52Speaker 3: Communities build programs around what's going on? If we've got
- 20:56Speaker 3: more brackup patients in one area, how do we get
- 20:59Speaker 3: the Susan g Coman's of the world to say, come here,
- 21:02Speaker 3: let's invest Let's do a study here, let's invest some
- 21:06Speaker 3: money here to help these patients.
- 21:08Speaker 1: Invest in Alabama. I love a chief Medical Officer Southern Research,
- 21:11Speaker 1: doctor Khali Brown. Thank you so much for joining me
- 21:13Speaker 1: this week on Viewpoint Alabama.
- 21:14Speaker 2: Thank you for having me.
- 21:15Speaker 1: This is National Arthritis Awareness Month and also National Osteoporosis
- 21:20Speaker 1: Prevention Month. Anyone over the age of fifty has an
- 21:23Speaker 1: increased risk of arthritis in osteoporosis, but everyone should be
- 21:26Speaker 1: concerned about preventing it. Hello, I'm John mountsin This is
- 21:29Speaker 1: Viewpoint Alabama on the Alabama Radio Network. Joining me right
- 21:32Speaker 1: now is Joshlyn Witstein. She is a board certified orthopedic
- 21:36Speaker 1: surgeon and the Associate Professor of Orthopedic Surgery at Duke
- 21:39Speaker 1: University School of Medicine. She's also the co author of
- 21:42Speaker 1: the Complete Bone and Joint Health Plan. Jocelyn, Welcome to
- 21:45Speaker 1: Viewpoint Alabama.
- 21:46Speaker 4: Thank you for having me, Jocelyn.
- 21:48Speaker 1: I always say an ounce of prevention is worth a
- 21:50Speaker 1: pound of cure, but easier said than done. First question,
- 21:54Speaker 1: how do we prevent these things?
- 21:56Speaker 5: Yes, we would all love to escape these problems, wouldn't
- 21:59Speaker 5: we First maybe to think of the scale of the problem,
- 22:03Speaker 5: which is that twenty percent of adults will experience arthritis,
- 22:08Speaker 5: and one in three women will experience osteoporosis related fractures.
- 22:14Speaker 5: One in five men will as well, so it's extremely common,
- 22:17Speaker 5: and of course it's an age related process. And well,
- 22:21Speaker 5: we really can't entirely prevent arthritis. There are so many
- 22:26Speaker 5: things we can do to make this less symptomatic and
- 22:31Speaker 5: maybe progress lower. And then when we think about osteoporosis
- 22:34Speaker 5: that is actually quite preventable through dietary choices and specific
- 22:41Speaker 5: exercises and for women actually use of hormone therapy.
- 22:45Speaker 1: We'll talk about arthritis. I always consider that there is
- 22:48Speaker 1: two major areas. There's osteoarthritis and rheumatoid arthritis. Can you
- 22:53Speaker 1: explain the fundamental difference between those two.
- 22:56Speaker 5: Yes, there's actually more than two types, but I like
- 22:58Speaker 5: to use those two types as an explanation for you know,
- 23:03Speaker 5: variations and types of arthritis because they're kind of at
- 23:06Speaker 5: the opposite.
- 23:07Speaker 4: End of the spectrum.
- 23:08Speaker 5: But when we think about osteoarthritis, this is your classic
- 23:11Speaker 5: wear and tear, you know, age related arthritis that is
- 23:15Speaker 5: from just overload of the joint like a you know,
- 23:19Speaker 5: just mechanical like you're just using these joints over the
- 23:21Speaker 5: course of your lifetime. And at the opposite end of
- 23:24Speaker 5: the expect of the spectrum is rheumatoid arthritis, which is
- 23:28Speaker 5: an inflammatory condition. This is an autoimmune condition where inflammation
- 23:33Speaker 5: and your joints is literally destroying the surface or what
- 23:37Speaker 5: we call the cartilage of the of the joint. There
- 23:39Speaker 5: are other types actually in between. I would say there's
- 23:43Speaker 5: something called post traumatic earthritis. Like if you have an
- 23:45Speaker 5: injury like tear your acl you get some inflammation in
- 23:48Speaker 5: your need, you're more likely to develop arthritis. And there's
- 23:51Speaker 5: also menopause arthritis, which is arthritis related to the inflammation
- 23:55Speaker 5: that occurs in women as their estrogen levels drop.
- 23:58Speaker 1: So it sounds like inflammation is an issue. And then
- 24:00Speaker 1: also just as you mentioned, wear and tear, because that
- 24:03Speaker 1: cartilage that makes it to where our bones can slide
- 24:06Speaker 1: at best each other easily eventually wears down and there's
- 24:10Speaker 1: not much you can do, I guess to I mean,
- 24:13Speaker 1: things wear out through time, but there's ways that we
- 24:16Speaker 1: can prevent them from I guess wearing as quickly from
- 24:20Speaker 1: And I've heard all sorts of like things that might
- 24:22Speaker 1: go in the category of old wives tales like oh,
- 24:24Speaker 1: you shouldn't you shouldn't run on concrete, or you should
- 24:27Speaker 1: get better shoes or that kind of thing. And then
- 24:29Speaker 1: I've also heard where you should take this medicine or
- 24:31Speaker 1: that medicine. What are some of the I guess, the
- 24:33Speaker 1: clinically proven things we can do from a lifestyle standpoint,
- 24:37Speaker 1: and then we can talk about a pharmacologic standpoint.
- 24:39Speaker 5: There are a lot of myths about arthritis.
- 24:41Speaker 4: This is true.
- 24:42Speaker 5: Even the wear and tereror type of arthritis does have
- 24:45Speaker 5: some component of inflammation. So you know, lowering your inflammation
- 24:50Speaker 5: in your body. Eating a diet that is anti inflammatory
- 24:53Speaker 5: can help. Maintaining a healthy body weight can help. Obest
- 24:58Speaker 5: people are more likely to have arthrit and not even
- 25:02Speaker 5: just in their weight brain joids, just in general and
- 25:04Speaker 5: all joints in their body. So losing weight can help
- 25:08Speaker 5: and also help slow the progression of earthritis. If you
- 25:12Speaker 5: have some mild arthritis, choosing activities that are not as
- 25:16Speaker 5: high impact or load on your joint, like running and jumping,
- 25:20Speaker 5: can help minimize the symptoms of arthritis. As you mentioned,
- 25:24Speaker 5: running is often blamed for you know, we blame running
- 25:28Speaker 5: on you know, causingthis, but it actually doesn't cause earthritis.
- 25:32Speaker 5: Runners are not more likely to have arthritis. They are
- 25:34Speaker 5: less likely to have arthritis. However, if you already have arthritis,
- 25:38Speaker 5: running may exacerbate it. And then there are supplements that
- 25:44Speaker 5: help support our joint health.
- 25:46Speaker 1: So it sounds like inflammation is an issue from a
- 25:49Speaker 1: systemic standpoint, and also there's just general wear and tear.
- 25:52Speaker 1: Things wear out over time, and then you have to
- 25:55Speaker 1: think about like these old wives tales you always hear,
- 25:58Speaker 1: like you shouldn't run on concrete, you'll develop authritis, or
- 26:02Speaker 1: you shouldn't pop your knuckles or all of these things
- 26:05Speaker 1: that you hear. What are some proven treatments at clinically
- 26:07Speaker 1: proven treatments for prevention and treatment Author Authritis. We'll talk
- 26:12Speaker 1: about both lifestyle and then we'll talk about pharmacologic treatments.
- 26:16Speaker 5: Well, I think certainly a good diet that includes you know, calcium,
- 26:20Speaker 5: vitamin D, micronutrients that you need for bone health, like
- 26:24Speaker 5: magnesium and you know, vitamin K, vitamin C, things like
- 26:28Speaker 5: that all important for bone health. But activity that includes
- 26:32Speaker 5: strength training and some impact is extremely important for establishing
- 26:35Speaker 5: that you know, base of your peak bone density, which
- 26:38Speaker 5: peaks at age thirty. And then after the age of thirty,
- 26:42Speaker 5: we do start to gradually lose bone density about one
- 26:45Speaker 5: percent per year and then, unfortunately for women, when they
- 26:48Speaker 5: reach menopause with estrogen withdrawal, that becomes.
- 26:51Speaker 4: A two percent per year loss.
- 26:52Speaker 5: And then the thing that we really, I think don't
- 26:55Speaker 5: give enough credit to is hormone therapy. So when women
- 26:58Speaker 5: go through menopause doesn't have estrogen withdrawal, they can be
- 27:02Speaker 5: treated with hormone therapy that includes estrogen and this significantly
- 27:07Speaker 5: reduces risk of osteoporosis and reduces risk of hip fractures
- 27:10Speaker 5: by thirty percent.
- 27:11Speaker 4: So there is so much that we can do.
- 27:14Speaker 5: It's not like once you have it, you know it's
- 27:15Speaker 5: doomsday and there's nothing you can do.
- 27:17Speaker 4: But it's best to be proactive and doctor Wistein.
- 27:20Speaker 1: One of the things that I've heard throughout my lifetime
- 27:22Speaker 1: for my mother, my grandmother, is you shouldn't slouch, you
- 27:25Speaker 1: should have better posture. It's better for you so you
- 27:27Speaker 1: won't develop you know, poor posture and arthritis and all
- 27:31Speaker 1: these other things. Is there any truth to that?
- 27:34Speaker 5: Well, I think good posture is extremely important. It's basically
- 27:39Speaker 5: exercise all day for your core muscula sure, and it
- 27:44Speaker 5: does help your back for sure as well. Not to
- 27:46Speaker 5: be in the slouched posture unfortunately, and today's landscape, everyone's
- 27:50Speaker 5: on their tablet or iPad or phone or whatever, and
- 27:53Speaker 5: I think there's even worsening posture and slouching even in teenagers.
- 27:58Speaker 5: But you know, I think being more active, being more
- 28:01Speaker 5: engaged in strength training and using.
- 28:02Speaker 4: Your core, thinking about your poster those are all good things.
- 28:05Speaker 1: It's true we do seem to spend a lot of
- 28:06Speaker 1: time looking down, and I know that's going to cause
- 28:08Speaker 1: some problems at least in your cervical spine, if not
- 28:11Speaker 1: in your spine as a whole. Plus, just by being
- 28:13Speaker 1: on your devices, you're not as active as we used.
- 28:16Speaker 4: To be, right, Yeah, that's true, Jocelyn.
- 28:19Speaker 1: In your book The Complete Bone and Joint Health Plan,
- 28:22Speaker 1: are there some simple steps that you lay out that
- 28:24Speaker 1: people should take every single day. I'm not discouraging them
- 28:27Speaker 1: from going out and buying the book, but right now
- 28:29Speaker 1: some simple steps they can take every day to help
- 28:33Speaker 1: them prevent developing these problems later in life.
- 28:36Speaker 5: Absolutely. In The Complete Bone and Joint Health Plan, we
- 28:39Speaker 5: try to make this really easy for people. Basically your
- 28:44Speaker 5: own you know what. The actions that you can take
- 28:47Speaker 5: are in the form of educating yourself about what causes
- 28:50Speaker 5: arthritis and osteoporosis so that you can know how to
- 28:52Speaker 5: attack this problem. There are dietary choices you can make,
- 28:56Speaker 5: and we outline how to follow a diet that meets
- 28:59Speaker 5: both anti and slamsy needs and bone health needs. We
- 29:02Speaker 5: provide recipes that allow people to combine ingredients that nourish
- 29:06Speaker 5: both their bones and their joints, and we provide the
- 29:09Speaker 5: exercises that you can incorporate several days a week to
- 29:13Speaker 5: be proactive about maintaining your muscle mass, maintaining your bone density.
- 29:17Speaker 5: And then lastly, I think the most helpful section may
- 29:20Speaker 5: be the frequently asked question section, where my co author,
- 29:24Speaker 5: Sitney nur Skorsky, who's a registered dietitian and fitness instructor,
- 29:27Speaker 5: and myself include all of the things that her clients
- 29:31Speaker 5: and my patients ask me every day.
- 29:33Speaker 1: Doctor Jocelyn Witstein, thank you so much for joining us
- 29:36Speaker 1: this week off Viewpoint Alabama.
- 29:37Speaker 5: Thanks for having me.
- 29:38Speaker 1: You've been listening to Viewpoint Alabama, a public affairs program
- 29:41Speaker 1: from the Alabama Radio Network. The opinions expressed on Viewpoint
- 29:45Speaker 1: Alabama are not necessarily those of the staff, management, or
- 29:48Speaker 1: advertisers of this station.